JENNIE KRULL: Open Payments
NPI 1518322510 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,364 in 119 payments from 15 companies in 2025. Trend: 2023 $456 · 2024 $2,097 · 2025 $3,364
Food & beverage: $3,364
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $692 |
| Otsuka America Pharmaceutical, Inc. | 16 | $534 |
| Alkermes, Inc. | 9 | $245 |
| Janssen Pharmaceuticals, Inc | 11 | $228 |
| Collegium Pharmaceutical, Inc. | 8 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $221 |
| Teva Pharmaceuticals USA, Inc. | 9 | $200 |
| E.R. Squibb & Sons, L.L.C. | 5 | $191 |
| Lundbeck LLC | 6 | $160 |
| ABBVIE INC. | 9 | $138 |
Products named: REXULTI, FANAPT, HETLIOZ, Jornay PM, CAPLYTA, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
